A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs
Tóm tắt
Từ khóa
Tài liệu tham khảo
Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775–1789. https://doi.org/10.1101/gr.132159.111
Cabili M, Trapnell C, Goff L et al (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25:1915–1927. https://doi.org/10.1101/gad.17446611
Huarte M (2015) The emerging role of lncRNAs in cancer. Nat Med 21:1253–1261. https://doi.org/10.1038/nm.3981
Schmitt AM, Chang HY (2016) Long noncoding RNAs in cancer pathways. Cancer Cell 29:452–463. https://doi.org/10.1016/j.ccell.2016.03.010
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330
Huang J, Samson P, Perkins SM, Ansstas G, Chheda MG, DeWees TA, Tsien CI, Robinson CG et al (2017) Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base. J Neuro-Oncol 131:593–601. https://doi.org/10.1007/s11060-016-2331-6
Ducray F, Idbaih A, Wang X-W, Cheneau C, Labussiere M, Sanson M (2011) Predictive and prognostic factors for gliomas. Expert Rev Anticancer Ther 11:781–789. https://doi.org/10.1586/era.10.202
Carninci P, Kasukawa T, Katayama S et al (2005) The transcriptional landscape of the mammalian genome. Science 309:1559–1563. https://doi.org/10.1126/science.1112014
Ravasi T, Suzuki H, Pang KC, Katayama S, Furuno M, Okunishi R, Fukuda S, Ru K et al (2006) Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res 16:11–19. https://doi.org/10.1101/gr.4200206
Mehler MF, Mattick JS (2007) Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev 87:799–823. https://doi.org/10.1152/physrev.00036.2006
Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139
Qureshi IA, Mattick JS, Mehler MF (2010) Long non-coding RNAs in nervous system function and disease. Brain Res 1338:20–35
Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS (2008) Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A 105:712–716. https://doi.org/10.1073/pnas.0706729105
Amaral PP, Neyt C, Wilkins SJ, Askarian-Amiri ME, Sunkin SM, Perkins AC, Mattick JS (2009) Complex architecture and regulated expression of the Sox2ot locus during vertebrate development. RNA 15:2013–2027. https://doi.org/10.1261/rna.1705309
Johnson R, Teh CH-L, Jia H, Vanisri RR, Pandey T, Lu ZH, Buckley NJ, Stanton LW et al (2009) Regulation of neural macroRNAs by the transcriptional repressor REST. RNA 15:85–96. https://doi.org/10.1261/rna.1127009
Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L et al (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595–600. https://doi.org/10.1038/nature04678
Wang J, Zhao H, Fan Z, Li G, Ma Q, Tao Z, Wang R, Feng J et al (2017) Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1-dependent M1 microglial polarization. Stroke 48:2211–2221. https://doi.org/10.1161/STROKEAHA.117.017387
Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK (2008) The DISC locus in psychiatric illness. Mol Psychiatry 13:36–64. https://doi.org/10.1038/sj.mp.4002106
Zhang X, Sun S, Pu JKS, Tsang ACO, Lee D, Man VOY, Lui WM, Wong STS et al (2012) Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 48:1–8. https://doi.org/10.1016/J.NBD.2012.06.004
Reon BJ, Anaya J, Zhang Y, Mandell J, Purow B, Abounader R, Dutta A (2016) Expression of lncRNAs in low-grade gliomas and glioblastoma multiforme: an in silico analysis. PLoS Med 13:e1002192. https://doi.org/10.1371/journal.pmed.1002192
Li R, Qian J, Wang Y-Y, Zhang JX, You YP (2014) Long noncoding RNA profiles reveal three molecular subtypes in glioma. CNS Neurosci Ther 20:339–343. https://doi.org/10.1111/cns.12220
Wang W, Zhao Z, Yang F, Wang H, Wu F, Liang T, Yan X, Li J et al (2018) An immune-related lncRNA signature for patients with anaplastic gliomas. J Neuro-Oncol 136:263–271. https://doi.org/10.1007/s11060-017-2667-6
Wang W, Yang F, Zhang L et al (2016) LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas. Oncotarget 7:77225–77236. https://doi.org/10.18632/oncotarget.12624
Zhang X-Q, Sun S, Lam K-F, Kiang KMY, Pu JKS, Ho ASW, Lui WM, Fung CF et al (2013) A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol Dis 58:123–131. https://doi.org/10.1016/J.NBD.2013.05.011
Chen G, Cao Y, Zhang L et al (2017) Analysis of long non-coding RNA expression profiles identifies novel lncRNA biomarkers in the tumorigenesis and malignant progression of gliomas. Oncotarget 8:67744–67753. https://doi.org/10.18632/oncotarget.18832
van de Vijver MJ, He YD, van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009. https://doi.org/10.1056/NEJMoa021967
Spentzos D, Levine D, Ramoni M et al (2004) Gene expression signature with independent prognostic significance in epithelial ovarian cancer. J Clin Oncol 22:4700–4710. https://doi.org/10.1200/jco.2004.04.070
Bullinger L, Döhner K, Bair E, Fröhling S, Schlenk RF, Tibshirani R, Döhner H, Pollack JR (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350:1605–1616. https://doi.org/10.1056/NEJMoa031046
Chibon F (2013) Cancer gene expression signatures-the rise and fall? Eur J Cancer 49:2000–2009. https://doi.org/10.1016/j.ejca.2013.02.021
Bao ZS, Chen HM, Yang MY, Zhang CB, Yu K, Ye WL, Hu BQ, Yan W et al (2014) RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res 24:1765–1773. https://doi.org/10.1101/gr.165126.113
Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D et al (2012) GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22:1760–1774. https://doi.org/10.1101/gr.135350.111
Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL (2015) StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33:290–295. https://doi.org/10.1038/nbt.3122
Tibshirani R (1997) The lasso method for variable selection in the cox model. Stat Med 16:385–395. https://doi.org/10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
Tibshirani R (2011) Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc Ser B Stat Methodol 73:273–282. https://doi.org/10.1111/j.1467-9868.2011.00771.x
Goeman JJ (2010) L1 penalized estimation in the Cox proportional hazards model. Biom J 52:70–84. https://doi.org/10.1002/bimj.200900028
Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S et al (2011) Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood 118:1350–1358. https://doi.org/10.1182/blood-2011-03-345272
Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350:1828–1837. https://doi.org/10.1056/NEJMoa032520
Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33: . doi: https://doi.org/10.18637/jss.v033.i01
Raykar VC, Steck H, Krishnapuram B, et al On ranking in survival analysis: bounds on the concordance index
Gerds TA, Kattan MW, Schumacher M, Yu C (2013) Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring. Stat Med 32:2173–2184. https://doi.org/10.1002/sim.5681
Kim TK, Hemberg M, Gray JM (2015) Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers. Cold Spring Harb Perspect Biol 7:a018622. https://doi.org/10.1101/cshperspect.a018622
Panzitt K, Tschernatsch MMO, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H et al (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132:330–342. https://doi.org/10.1053/J.GASTRO.2006.08.026
Du Z, Fei T, Verhaak RGW et al (2013) Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol 20:908–913. https://doi.org/10.1038/nsmb.2591
Mohankumar S, Patel T (2016) Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer. Brief Funct Genomics 15:249–256. https://doi.org/10.1093/bfgp/elv058
Zhou M, Zhang Z, Zhao H, et al (2017) An immune-related six-lncRNA signature to improve prognosis prediction of glioblastoma multiforme. Mol Neurobiol 1–14
Angileri FF, Aguennouz M, Conti A et al (2008) Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Cancer 112:2258–2266. https://doi.org/10.1002/cncr.23407
Korkolopoulou P, Levidou G, Saetta AA, el-Habr E, Eftichiadis C, Demenagas P, Thymara I, Xiromeritis K et al (2008) Expression of nuclear factor-κB in human astrocytomas: relation to pIκBa, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. Hum Pathol 39:1143–1152. https://doi.org/10.1016/J.HUMPATH.2008.01.020
Schaefer LK, Ren Z, Fuller GN, Schaefer TS (2002) Constitutive activation of Stat3α in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 21:2058–2065. https://doi.org/10.1038/sj.onc.1205263
Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N et al (2008) The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res 14:8228–8235. https://doi.org/10.1158/1078-0432.CCR-08-1329
Puliyappadamba VT, Hatanpaa KJ, Chakraborty S, Habib AA (2014) The role of NF-κB in the pathogenesis of glioma. Mol Cell Oncol 1:e963478. https://doi.org/10.4161/23723548.2014.963478
Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS (2013) Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Oncogene 32:5144–5155. https://doi.org/10.1038/onc.2012.546
Coupienne I, Bontems S, Dewaele M, Rubio N, Habraken Y, Fulda S, Agostinis P, Piette J (2011) NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy. Biochem Pharmacol 81:606–616. https://doi.org/10.1016/J.BCP.2010.12.015